Answer
For myocardial infarction during pregnancy, Metalyse (tenecteplase) has limited human data and is not considered teratogenic, but animal studies found maternal bleeding with deaths and occasional fetal loss after repeated dosing, so treatment benefits must be weighed against potential risks.
Sources for this answer
- Metalyse 10,000 unitsBoehringer Ingelheim Limited · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 10Document updated
Sources checked